Q32 Bio Market Sentiment

SPY736.53+0.17%QQQ657.50+0.21%BTC/USD75,683.30−0.08%DIA512.52+0.06%GLD373.37+0.23%TLT81.85−0.09%

Premium Services

Q32 Bio Inc

QTTBNASDAQ

Trade with Public

$9.25

0.404.52%

Last update: Nov 6, 4:00 PM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Wed Nov 4th, before the market open

Q32 Bio Market Sentiment - Benzinga

Q32 Bio Market Sentiment

Market sentiment signals for Q32 Bio (QTTB): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▼ 27.0% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Outperform

14 analysts

Options Flow (P/C)

0.00

More calls — Bullish

53 calls · 0 puts

Avg Consensus PT

$33

+253.2%

Highest Price Target

$95

+927.0%

Wells Fargo

Lowest Price Target

-67.6%

BMO Capital

Short Interest

27.0%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 12, 2026	Leerink Partners	Will Soghikian—	+332.4%	$40	Initiate	Outperform
Sep 28, 2026	Jefferies	Maury Raycroft—	+213.5%	$29	Initiate	Buy
Aug 24, 2026	Morgan Stanley	Judah Frommer—	+267.6%	$34	Initiate	Overweight
Jul 28, 2026	HC Wainwright & Co.	Joseph Pantginis—	+289.2%	$13 → $36	Maintained	Buy
Jul 13, 2026	Wells Fargo	Derek Archila—	+613.5%	$66	Upgrade	Equal-Weight→Overweight
Jul 13, 2026	Oppenheimer	Jay Olson—	+332.4%	$20 → $40	Maintained	Outperform
May 22, 2026	Mizuho	Joseph Catanzaro—	+51.4%	$14	Initiate	Outperform
May 18, 2026	Cantor Fitzgerald	——	—	—	Initiate	Overweight
May 5, 2026	HC Wainwright & Co.	Joseph Pantginis—	+40.5%	$13 → $13	Maintained	Buy
Feb 25, 2026	HC Wainwright & Co.	Joseph Pantginis—	+40.5%	$13	Initiate	Buy
Mar 12, 2025	Wells Fargo	Derek Archila—	+62.2%	$16 → $15	Maintained	Equal-Weight
Feb 11, 2025	BMO Capital	Etzer Darout—	-67.6%	$22 → $3	Downgrade	Outperform→Market Perform
Feb 11, 2025	Piper Sandler	Christopher Raymond—	-56.8%	$20 → $4	Downgrade	Overweight→Neutral
Dec 12, 2024	BMO Capital	Etzer Darout—	+137.8%	$64 → $22	Maintained	Outperform
Dec 12, 2024	Guggenheim	Yatin Suneja—	—	—	Downgrade	Buy→Neutral
Dec 11, 2024	Oppenheimer	Jay Olson—	+116.2%	$80 → $20	Maintained	Outperform
Dec 11, 2024	Piper Sandler	Christopher Raymond—	+116.2%	$85 → $20	Maintained	Overweight
Dec 11, 2024	Wells Fargo	Derek Archila—	+73.0%	$95 → $16	Downgrade	Overweight→Equal-Weight
Dec 11, 2024	Leerink Partners	Thomas Smith—	-2.7%	$68 → $9	Downgrade	Outperform→Market Perform
Dec 11, 2024	Raymond James	Steven Seedhouse—	+137.8%	$90 → $22	Downgrade	Strong Buy→Outperform
Dec 6, 2024	BMO Capital	Etzer Darout—	+591.9%	$64	Initiate	Outperform
Oct 24, 2024	Raymond James	Steven Seedhouse—	+873.0%	$90	Initiate	Strong Buy
Sep 11, 2024	Wells Fargo	Sarah Akers—	+927.0%	$95	Initiate	Overweight
Jun 17, 2024	Guggenheim	Yatin Suneja—	+981.1%	$100	Initiate	Buy
May 21, 2024	Leerink Partners	Thomas Smith—	+483.8%	$54	Initiate	Outperform

Q32 Bio Inc

Q32 Bio Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch